Evolent Health, Inc. EVH EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Evolent Health, Inc.’s reported figures.
The official record: Evolent Health, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Evolent Health, Inc.'s ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Evolent Health, Inc.'s EBITDA?
- Evolent Health, Inc. (EVH) reported EBITDA of $10.96M in Q1 2026.
- How has Evolent Health, Inc.'s EBITDA changed year-over-year?
- Evolent Health, Inc.'s EBITDA decreased by 51.2% year-over-year, from $22.44M to $10.96M.
- What is the long-term trend for Evolent Health, Inc.'s EBITDA?
- Over 4 years (2021 to 2025), Evolent Health, Inc.'s EBITDA has grown at a 102.1% compound annual growth rate (CAGR), from $17.63M to -$294.29M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.